MAPKAPK3: A Potential Drug Target Or Biomarker for Diseases (G7867)

Target Name: MAPKAPK3

NCBI ID: G7867

MAPKAPK3

MAPKAPK3: A Potential Drug Target Or Biomarker for Diseases

MAPKAPK3, also known as Chromosome 3p kinase, is a gene that has been identified as a potential drug target or biomarker for various diseases.MAPKAPK3 is a non-coding RNA molecule that is located on Chromosome 3p and is involved in the regulation of cellular processes such as cell growth, differentiation, and survival.

Studies have shown that MAPKAPK3 is involved in the regulation of several cellular processes, including cell proliferation, migration, and invasion. It has been shown to play a role in the development and progression of several diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

One of the key functions of MAPKAPK3 is its role in the regulation of theMAPK/ERK signaling pathway. This signaling pathway is involved in the regulation of cellular processes such as cell growth, differentiation, and survival, and is a key factor in the development and progression of many diseases.

MAPKAPK3 is also involved in the regulation of the PI3K/AKT signaling pathway. This signaling pathway is involved in the regulation of cellular processes such as cell survival and angiogenesis, and is a key factor in the development and progression of many diseases, including cancer.

In addition to its role in the MAPK/ERK and PI3K/AKT signaling pathways, MAPKAPK3 is also involved in the regulation of several other cellular processes, including cell adhesion, migration, and invasion.

Given its involvement in so many cellular processes, MAPKAPK3 has been identified as a potential drug target or biomarker for a wide range of diseases. Studies have shown that blocking the activity of MAPKAPK3 has the potential to treat a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

In addition to its potential as a drug target, MAPKAPK3 has also been identified as a potential biomarker for several diseases. For example, studies have shown that the expression of MAPKAPK3 is significantly increased in the brains of individuals with Alzheimer's disease, a neurodegenerative disease.

Furthermore, MAPKAPK3 has also been shown to be involved in the regulation of fetal development and placenta development, which is a critical function for the growth and development of the fetus.

In conclusion, MAPKAPK3 is a gene that has been identified as a potential drug target or biomarker for a wide range of diseases. Its involvement in the regulation of cellular processes such as cell growth, differentiation, and survival makes it an attractive target for drug development. Furthermore, its potential as a biomarker for diseases such as Alzheimer's disease and fetal development make it an important addition to the toolkit for researchers studying these conditions.

Protein Name: MAPK Activated Protein Kinase 3

Functions: Stress-activated serine/threonine-protein kinase involved in cytokines production, endocytosis, cell migration, chromatin remodeling and transcriptional regulation. Following stress, it is phosphorylated and activated by MAP kinase p38-alpha/MAPK14, leading to phosphorylation of substrates. Phosphorylates serine in the peptide sequence, Hyd-X-R-X(2)-S, where Hyd is a large hydrophobic residue. MAPKAPK2 and MAPKAPK3, share the same function and substrate specificity, but MAPKAPK3 kinase activity and level in protein expression are lower compared to MAPKAPK2. Phosphorylates HSP27/HSPB1, KRT18, KRT20, RCSD1, RPS6KA3, TAB3 and TTP/ZFP36. Mediates phosphorylation of HSP27/HSPB1 in response to stress, leading to dissociate HSP27/HSPB1 from large small heat-shock protein (sHsps) oligomers and impair their chaperone activities and ability to protect against oxidative stress effectively. Involved in inflammatory response by regulating tumor necrosis factor (TNF) and IL6 production post-transcriptionally: acts by phosphorylating AU-rich elements (AREs)-binding proteins, such as TTP/ZFP36, leading to regulate the stability and translation of TNF and IL6 mRNAs. Phosphorylation of TTP/ZFP36, a major post-transcriptional regulator of TNF, promotes its binding to 14-3-3 proteins and reduces its ARE mRNA affinity leading to inhibition of dependent degradation of ARE-containing transcript. Involved in toll-like receptor signaling pathway (TLR) in dendritic cells: required for acute TLR-induced macropinocytosis by phosphorylating and activating RPS6KA3. Also acts as a modulator of Polycomb-mediated repression

The "MAPKAPK3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MAPKAPK3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets